ITW REAGENTS
ITW Reagents is fully integrated by AppliChem GmbH and PanReac Química SLU companies, under unique commercial brand PanReac AppliChem. The Division has two production plants in Spain and Germany.
With 75 years’ of experience, ITW Reagents is a Chemical producer of high quality chemicals for pharmaceutical manufacturing processes.
One of these processes is the pH adjustment in pharmaceutical production. In this process it is important to use reagents of the appropriate quality grade. Laboratory products are not suitable for this particular application as some important certificates requested by authorities will be missing.
Main advantages of PanReac AppliChem products:
- Acids and bases at different concentrations for different applications.
- Pharma grade: specifications according to main pharmacopoeias (USP and Ph. Eur.).
- Documents and certificates that regulatory bodies require: BSE / TSE, GMO, residual solvents, allergens, trace metal residues, etc.
- Different pack sizes are available to adjust your particular needs.
For further information contact us at customerservice.es@itwreagents.com
Contact Details:
Company name: ITW REAGENTS
Website:www.itwreagents.comE-mail: customerservice.es@itwreagents.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
